- Home
- RLAY vs SCHL Comparison
RLAY vs SCHL Comparison
Compare RLAY & SCHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RLAY
- SCHL
- Stock Information
- Founded
- RLAY 2015
- SCHL 1920
- Country
- RLAY United States
- SCHL United States
- Employees
- RLAY N/A
- SCHL N/A
- Industry
- RLAY Biotechnology: Biological Products (No Diagnostic Substances)
- SCHL Books
- Sector
- RLAY Health Care
- SCHL Consumer Discretionary
- Exchange
- RLAY Nasdaq
- SCHL Nasdaq
- Market Cap
- RLAY 1.0B
- SCHL 644.1M
- IPO Year
- RLAY 2020
- SCHL 1987
- Fundamental
- Price
- RLAY $6.15
- SCHL $27.67
- Analyst Decision
- RLAY Strong Buy
- SCHL Strong Buy
- Analyst Count
- RLAY 9
- SCHL 1
- Target Price
- RLAY $16.00
- SCHL $37.00
- AVG Volume (30 Days)
- RLAY 2.2M
- SCHL 184.3K
- Earning Date
- RLAY 11-06-2025
- SCHL 12-18-2025
- Dividend Yield
- RLAY N/A
- SCHL 2.89%
- EPS Growth
- RLAY N/A
- SCHL N/A
- EPS
- RLAY N/A
- SCHL N/A
- Revenue
- RLAY $8,355,000.00
- SCHL $1,613,900,000.00
- Revenue This Year
- RLAY $27.30
- SCHL $3.78
- Revenue Next Year
- RLAY $7.43
- SCHL $4.56
- P/E Ratio
- RLAY N/A
- SCHL N/A
- Revenue Growth
- RLAY N/A
- SCHL 0.97
- 52 Week Low
- RLAY $1.78
- SCHL $15.77
- 52 Week High
- RLAY $7.64
- SCHL $29.59
- Technical
- Relative Strength Index (RSI)
- RLAY 45.56
- SCHL 43.75
- Support Level
- RLAY $6.64
- SCHL $27.94
- Resistance Level
- RLAY $7.42
- SCHL $28.58
- Average True Range (ATR)
- RLAY 0.44
- SCHL 0.71
- MACD
- RLAY -0.19
- SCHL -0.22
- Stochastic Oscillator
- RLAY 8.31
- SCHL 7.54
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).
About SCHL Scholastic Corporation
Scholastic Corp is an American publishing and education media company that focuses on books and educational material for schools, teachers, parents, and children. It creates print, digital, and audiobooks, learning materials and programs, classroom magazines, and other products that support children's learning and reading both at home and at school. The company also owns rights to various books, including Harry Potter, Dog Man, and The Hunger Games among others. It has three reportable segments Children's Book Publishing and Distribution, Education Solutions, and International. The majority of its revenue is from the Children's Book Publishing and Distribution segment.